Deciphering the unusual HLA-A2/Melan-A/MART-1- specific TCR repertoire in humans

European Journal of Immunology

Volumn 44, Issue 9, 2014, Pages 2567-2570

  Romero, Pedro ^a   Speiser, Daniel E ^a   Rufer, Nathalie ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Central tolerance; Humanmedullary thymic epithelial cells; MART 1; Melanoma; Promiscuous gene expression

Indexed keywords

EPITOPE; MELAN A; MLANA PROTEIN, HUMAN;

CD8+ T LYMPHOCYTE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN MEDULLARY THYMIC EPITHELIAL CELLS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; MART-1; MELANOMA; NOTE; PROMISCUOUS GENE EXPRESSION; THYMUS; TRANSCRIPTION INITIATION;

CENTRAL TOLERANCE; HUMAN MEDULLARY THYMIC EPITHELIAL CELLS; MART-1; MELANOMA; PROMISCUOUS GENE EXPRESSION;

CD8-POSITIVE T-LYMPHOCYTES; EPITHELIAL CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; MALE; MART-1 ANTIGEN; THYMUS GLAND; TRANSCRIPTION INITIATION, GENETIC;

EID: 84907854816     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445004     Document Type: Note

References (29)

1. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S. et al., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 1994. 180: 35-42.
2. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T. et al., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 1994. 91: 3515-3519.
3. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E. et al., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 1994. 180: 347-352.
4. Hickman, H. D. and Yewdell, J. W., Going Pro to enhance T-cell immunogenicity: easy as pi?. Eur. J. Immunol. 2013. 43: 2814-2817.
5. Benlalam, H., Labarriere, N., Linard, B., Derre, L., Diez, E., Pandolfino, M. C., Bonneville, M. et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy. Eur. J. Immunol. 2001. 31: 2007-2015.
6. Kawakami, Y., Dang, N., Wang, X., Tupesis, J., Robbins, P. F., Wang, R. F., Wunderlich, J. R. et al., Recognition of shared melanoma antigens in association withmajor HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J. Immunother. 2000. 23: 17-27.
7. Romero, P., Gervois, N., Schneider, J., Escobar, P., Valmori, D., Pannetier, C., Steinle, A. et al., Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201- restricted Melan-A/MART-1 antigenic peptide in melanoma. J. Immunol. 1997. 159: 2366-2374.
8. Valmori, D., Fonteneau, J. F., Lizana, C. M., Gervois, N., Lienard, D., Rimoldi, D., Jongeneel, V. et al., Enhanced generation of specific tumorreactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 1998. 160: 1750-1758.
9. Sliz, P., Michielin, O., Cerottini, J.-C., Luescher, I. F., Romero, P., Karplus, M. and Wiley, D. C. Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes. J. Immunol. 2001. 167: 3276-3284.
10. Derre, L., Ferber, M., Touvrey, C., Devevre, E., Zoete, V., Leimgruber, A., Romero, P. et al., A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J. Immunol. 2007. 179: 7635-7645.
11. Borbulevych, O. Y., Insaidoo, F. K., Baxter, T. K., Powell, D. J., Jr., Johnson, L. A., Restifo, N. P. and Baker, B. M., Structures of MART-126/27- Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J. Mol. Biol. 2007. 372: 1123-1136.
12. Romero, P., Dunbar, P. R., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J. L. et al., Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 1998. 188: 1641-1650.
13. Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Lienard, D., Lejeune, F., Fleischhauer, K. et al., High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 1999. 190: 705-715.
14. Voelter, V., Rufer, N., Reynard, S., Greub, G., Brookes, R., Guillaume, P., Grosjean, F. et al., Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor. Int. Immunol. 2008. 20: 1087-1096.
15. Pittet, M. J., Gati, A., Le Gal, F. A., Bioley, G., Guillaume, P., de Smedt, M., Plum, J. et al., Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex. J. Immunol. 2006. 176: 2330- 2336.
16. Alanio, C., Lemaitre, F., Law, H. K., Hasan, M. and Albert, M. L., Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. Blood 2010. 115: 3718-3725.
17. Legoux, F., Debeaupuis, E., Echasserieau, K., De La Salle, H., Saulquin, X. and Bonneville, M., Impact of TCR reactivity and HLA phenotype on naive CD8 T cell frequency in humans. J. Immunol. 2010. 184: 6731-6738.
18. Moon, J. J., Chu, H. H., Pepper, M., McSorley, S. J., Jameson, S. C., Kedl, R.M. and Jenkins, M. K., Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007. 27: 203-213.
19. Pittet, M., Zippelius, A., Valmori, D., Speiser, D., Cerottini, J. C. and Romero, P.,Melan-A/MART-1-specific CD8 T cells: from thymus to tumor. Trends Immunol. 2002. 23: 325-328.
20. Speiser, D., Lienard, D., Pittet, M., Batard, P., Rimoldi, D., Guillaume, P., Cerottini, J. C. et al., In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells. Eur. J. Immunol. 2002. 32: 731-741.
21. Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K. et al., Thymic selection generates a large T cell pool recognizing a self- peptide in humans. J. Exp. Med. 2002. 195: 485-494.
22. De Maziere, A. M., Muehlethaler, K., van Donselaar, E., Salvi, S., Davoust, J., Cerottini, J. C., Levy, F. et al., The melanocytic protein Melan-A/MART- has a subcellular localization distinct from typical melanosomal proteins. Traffic 2002. 3: 678-693.
23. Dietrich, P. Y., Le Gal, F. A., Dutoit, V., Pittet, M. J., Trautman, L., Zippelius, A., Cognet, I. et al., Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J. Immunol. 2003. 170: 5103-5109.
24. Trautmann, L., Labarriere, N., Jotereau, F., Karanikas, V., Gervois, N., Connerotte, T., Coulie, P. et al., Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. Eur. J. Immunol. 2002. 32: 3181-3190.
25. Gotter, J., Brors, B., Hergenhahn, M. and Kyewski, B.,Medullary epithelial cells of the human thymus express a highly diverse selection of tissuespecific genes colocalized in chromosomal clusters. J. Exp. Med. 2004. 199: 155-166.
26. Pittet, M. J., Rubio-Godoy, V., Bioley, G., Guillaume, P., Batard, P., Speiser, D., Luescher, I. et al., Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells. J. Immunol. 2003. 171: 1844-1849.
27. Pinto, S., Sommermeyer, D.,Michel, C. S. W., Schendel, D. J., Uckert,W., Blankenstein, T. and Kyewski, B., Mis-initiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency ofMART-1-specific T cells. Eur. J. Immunol. 2014. 44: 2811-2821.
28. Cole, D. K., Yuan, F., Rizkallah, P. J., Miles, J. J., Gostick, E., Price, D. A., Gao, G. F. et al., Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J. Biol. Chem. 2009. 284: 27281-27289.
29. Dutoit, V., Rubio-Godoy, V., Pittet, M. J., Zippelius, A., Dietrich, P. Y., Legal, F. A., Guillaume, P. et al., Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans. J. Exp. Med. 2002. 196: 207-216.